{"id":54310,"date":"2012-10-16T17:15:40","date_gmt":"2012-10-16T17:15:40","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/nextgxdx-launches-comprehensive-genetic-testing-platform-curating-information-on-more-than-10000-genetic-testing.php"},"modified":"2012-10-16T17:15:40","modified_gmt":"2012-10-16T17:15:40","slug":"nextgxdx-launches-comprehensive-genetic-testing-platform-curating-information-on-more-than-10000-genetic-testing","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/nextgxdx-launches-comprehensive-genetic-testing-platform-curating-information-on-more-than-10000-genetic-testing.php","title":{"rendered":"NextGxDx Launches Comprehensive Genetic Testing Platform, Curating Information on More Than 10,000 Genetic Testing &#8230;"},"content":{"rendered":"<p><p>    NASHVILLE, Tenn., Oct. 16, 2012 \/PRNewswire\/ -- NextGxDx, a    healthcare information technology company, today announced the    release of its online genetic testing platform that curates    information on the more than 10,000 genetic testing products    currently offered by FDA and CLIA certified labs in the U.S.    According to NextGxDx's research, the database is the most    comprehensive catalog of all the genetic testing products    available to U.S. healthcare providers. The company also found    the number of available tests is tenfold greater than    previously estimated by industry experts.  <\/p>\n<p>    The company intends to help implement strategies that further    clinical integration of genetic testing. The goal of the    platform is to speed the process of diagnosing, and thus    treating, patients with genetic diseases. The NextGxDx platform    allows healthcare providers and hospitals to easily identify    the appropriate genetic tests for their patients by searching    the database by symptoms or browsing by clinical specialty. The    platform also allows side-by-side comparison of tests, and the    company's partnerships with laboratories across the country    enable physicians to order tests directly from the NextGxDx    website.  <\/p>\n<p>    \"Our research shows there are nearly ten times more genetic    tests available today than commonly thought, and yet there has    not been a centralized, well-curated, user-friendly platform to    help healthcare providers find the right test for a patient.    Our platform brings together all the disparate information    about available genetic tests to help physicians find and order    the best test the first time,\" said Mark Harris, Ph.D., founder    and CEO of NextGxDx. \"In addition to facilitating the diagnosis    process, the technology we have developed will allow us to    maintain the most accurate catalog of genetic testing products    available.\"  <\/p>\n<p>    NextGxDx explores the factors informing and shaping the    industry in \"The Genetic Testing Landscape: Finding the Needle    in the Haystack\" a white paper released today. The paper    provides a comprehensive overview of the genetic testing    industry, including the size of the industry, how genetic tests    are used and how genetic information is communicated. It also    outlines key strategies for the future of clinical integration    of genetic testing and personalized medicine.  <\/p>\n<p>    Among the paper's key findings:  <\/p>\n<p>    \"This report is designed to establish a robust analysis of    genetic testing as it relates to the products currently    available for clinical use,\" said Jud Schneider, Ph.D.,    scientific director of NextGxDx and author of the white paper.    \"As personalized medicine becomes a clinical reality, we think    it's important for physicians to understand the scope and    trajectory of the genetic testing industry and how it may    impact their practices in the years ahead.\"  <\/p>\n<p>    The white paper is currently available for free download on the    NextGxDx website, <a href=\"http:\/\/www.NextGxDx.com\" rel=\"nofollow\">http:\/\/www.NextGxDx.com<\/a>.  <\/p>\n<p>    About NextGxDx  <\/p>\n<p>    NextGxDx is a healthcare information technology company that    provides a web-based genetic diagnostics platform allowing    hospitals and physicians to quickly and efficiently identify    appropriate genetic tests and cross-reference multiple test    providers. With the ability to research tests based on patient    symptoms, instantly compare tests across laboratories, and    determine existing institutional relationships, NextGxDx    provides physicians with a single destination for discovering,    comparing and ordering genetic tests. For more information,    visit <a href=\"http:\/\/www.NextGxDx.com\" rel=\"nofollow\">http:\/\/www.NextGxDx.com<\/a>.  <\/p>\n<p>    Media Contact:    Erin Lawley    615-946-9914    <a href=\"mailto:erin@lovell.com\">erin@lovell.com<\/a>  <\/p>\n<\/p>\n<p>Originally posted here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/nextgxdx-launches-comprehensive-genetic-testing-150000436.html;_ylt=A2KJ3CYzln1QnCAAA3z_wgt.\" title=\"NextGxDx Launches Comprehensive Genetic Testing Platform, Curating Information on More Than 10,000 Genetic Testing ...\">NextGxDx Launches Comprehensive Genetic Testing Platform, Curating Information on More Than 10,000 Genetic Testing ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NASHVILLE, Tenn., Oct. 16, 2012 \/PRNewswire\/ -- NextGxDx, a healthcare information technology company, today announced the release of its online genetic testing platform that curates information on the more than 10,000 genetic testing products currently offered by FDA and CLIA certified labs in the U.S. According to NextGxDx's research, the database is the most comprehensive catalog of all the genetic testing products available to U.S <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/nextgxdx-launches-comprehensive-genetic-testing-platform-curating-information-on-more-than-10000-genetic-testing.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-54310","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54310"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=54310"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54310\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=54310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=54310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=54310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}